CDT (STOCKS)
CDT Equity Inc. Common Stock
$0.710000
+0.014000 (+2.01%)
Prev close: $0.696000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Andrew Regan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.45M
- Employees
- 6
- P/E (TTM)
- —
- P/B (TTM)
- -0.01
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$2.47M |
| Operating Expenses | $36.76M |
| Research and Development | $5.05M |
| Other Operating Expenses | $31.70M |
| Operating Income/Loss | -$36.76M |
| Income/Loss From Continuing Operations After Tax | -$39.22M |
| Income/Loss From Continuing Operations Before Tax | -$39.22M |
| Interest Expense, Operating | $200.00K |
| Net Income/Loss | -$39.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.22M |
| Net Income/Loss Available To Common Stockholders, Basic | -$39.22M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.18K |
| Diluted Earnings Per Share | -$1.18K |
| Basic Average Shares | 33,300 |
| Diluted Average Shares | 33,300 |
| Assets | $5.65M |
| Current Assets | $4.38M |
| Cash | $1.50M |
| Other Current Assets | $2.88M |
| Noncurrent Assets | $1.27M |
| Fixed Assets | $269.00K |
| Other Non-current Assets | $1.00M |
| Liabilities | $12.82M |
| Current Liabilities | $12.82M |
| Accounts Payable | $1.91M |
| Other Current Liabilities | $10.91M |
| Noncurrent Liabilities | $0.00 |
| Equity | -$7.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$7.17M |
| Liabilities And Equity | $5.65M |
| Net Cash Flow From Operating Activities | -$15.56M |
| Net Cash Flow From Operating Activities, Continuing | -$15.56M |
| Net Cash Flow From Investing Activities | -$808.00K |
| Net Cash Flow From Investing Activities, Continuing | -$808.00K |
| Net Cash Flow From Financing Activities | $17.42M |
| Net Cash Flow From Financing Activities, Continuing | $17.42M |
| Net Cash Flow | $1.06M |
| Net Cash Flow, Continuing | $1.06M |
| Comprehensive Income/Loss | -$39.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.65M |
| Other Comprehensive Income/Loss | -$39.65M |